Literature DB >> 21533603

Effect of short hairpin RNA of Bcl-xL gene on biological behaviors of HepG-2 cells.

Duan Mengxi1, Yuan Hong, Wang Nan, Li Shijun, Jiang Yanmei.   

Abstract

To investigate the inhibitory effect of short hairpin RNA (shRNA) targeting the Bcl-xL gene on the apoptosis and proliferation of hepatocellular carcinoma HepG-2 cells. We constructed Bcl-xL shRNA, and transfected it into HepG-2 cells, then detected Bcl-xL gene expression on mRNA and protein levels by reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry, respectively. Cell proliferation was detected by MTT assay. Cell apoptosis and Bcl-2 and Bax expression were detected by flow cytometry. The expression of Bcl-xL was obviously inhibited by RNA interference. The inhibition rates of Bcl-xL mRNA and protein were 86.6 and 70.2%, respectively. Bcl-xL shRNA inhibited cell proliferation (P < 0.05), whereas promoted apoptosis (P < 0.01). After transfection of Bcl-xL shRNA in HepG-2 cells, the expression of Bcl-2 did not change, but Bax increased significantly. Bcl-xL shRNA effectively inhibits Bcl-xL gene expression and proliferation of HepG-2 cells and promotes apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533603     DOI: 10.1007/s12032-011-9949-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  15 in total

Review 1.  Gene silencing mediated by small interfering RNAs in mammalian cells.

Authors:  Michaela Scherr; Michael A Morgan; Matthias Eder
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

2.  Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

Authors:  Wei-Li Zhao; Marjan Ertault Daneshpouy; Nicolas Mounier; Josette Brière; Christophe Leboeuf; Louis-François Plassa; Elisabeth Turpin; Jean-Michel Cayuela; Jean-Claude Ameisen; Christian Gisselbrecht; Anne Janin
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

Review 3.  BCL-2 family proteins: critical checkpoints of apoptotic cell death.

Authors:  Nika N Danial
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

4.  Doxorubicin plus sorafenib in treatment of advanced hepatocellular carcinoma.

Authors:  Robert A Pazo Cid; Juan Lao; Manuela Lanzuela
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

5.  Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.

Authors:  D Luo; S C Cheng; H Xie; Y Xie
Journal:  Biochem Cell Biol       Date:  2000       Impact factor: 3.626

6.  Updates in the management of hepatocellular carcinoma.

Authors:  Robert Wong; Catherine Frenette
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-01

7.  Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.

Authors:  Eric T Sawey; Maia Chanrion; Chunlin Cai; Guanming Wu; Jianping Zhang; Lars Zender; Alice Zhao; Ronald W Busuttil; Herman Yee; Lincoln Stein; Dorothy M French; Richard S Finn; Scott W Lowe; Scott Powers
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

8.  Prognostic significance of Bcl-xL in human hepatocellular carcinoma.

Authors:  Jota Watanabe; Fumiki Kushihata; Kazuo Honda; Atsuro Sugita; Norihiko Tateishi; Katsumi Mominoki; Seiji Matsuda; Nobuaki Kobayashi
Journal:  Surgery       Date:  2004-06       Impact factor: 3.982

Review 9.  Mitochondria potential, bax "activation," and programmed cell death.

Authors:  C Michael Knudson; Nicholas M Brown
Journal:  Methods Mol Biol       Date:  2008

10.  Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases.

Authors:  Meike Broemer; Tencho Tenev; Kristoffer T G Rigbolt; Sophie Hempel; Blagoy Blagoev; John Silke; Mark Ditzel; Pascal Meier
Journal:  Mol Cell       Date:  2010-12-10       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.